BNR17

Serial Number 88348769
Registration 6913351
700

Registration Progress

Application Filed
Mar 20, 2019
Under Examination
Apr 7, 2020
Approved for Publication
Feb 11, 2020
Published for Opposition
Feb 11, 2020
Registered
Nov 29, 2022

Trademark Image

BNR17

Basic Information

Serial Number
88348769
Registration Number
6913351
Filing Date
March 20, 2019
Registration Date
November 29, 2022
Published for Opposition
February 11, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 29, 2022
Registration
Registered
Classes
001 005

Rights Holder

BIONEER CORPORATION

03
Address
8-11, Munpyeongseo-ro, Daedeok-gu
Daejeon 34302
KR

Ownership History

BIONEER CORPORATION

Original Applicant
03
Daejeon KR

BIONEER CORPORATION

Owner at Publication
03
Daejeon KR

BIONEER CORPORATION

Original Registrant
03
Daejeon KR

Legal Representation

Attorney
Jun-Hwa Jeong

Application History

45 events
Date Code Type Description Documents
Nov 29, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 29, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 26, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 25, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 2, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 2, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 21, 2022 IUAF S USE AMENDMENT FILED Loading...
Sep 21, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 29, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 25, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 25, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Mar 25, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 21, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 17, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Sep 17, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 17, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 25, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 23, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 23, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 23, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 11, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 7, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 7, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 7, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 7, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 11, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 11, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 22, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 9, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 9, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 9, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jan 9, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 9, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 6, 2020 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Dec 10, 2019 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Nov 23, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 22, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 22, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 22, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 6, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 6, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 6, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 31, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 8, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 23, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Anti-diabetic functional lactic acid bacteria for use in food manufacture
First Use Anywhere: 20180800
First Use in Commerce: Nov 12, 2021
Class 005
Microorganisms for medical purposes, namely, the treatment of obesity, Microorganisms for medical purposes, namely, the treatment of obesity, diabetes, atopy, visceral fat decrease; Probiotic microorganisms for medical purposes, namely, the treatment of obesity, diabetes, atopy, visceral fat decrease; Lactic acid bacterial preparations for medical use, namely, functional lactic acid bacteria for body fat breakdown and anti-obesity, functional lactic acid bacteria for improving immunity, functional lactic acid bacteria for improving skin diseases and atopic diseases and functional lactic acid bacteria for improving intestinal function and irritable colon symptoms; Medicines for the prevention and treatment of obesity, immune disorder, skin diseases, atopic diseases and intestinal disorders for veterinary purposes; Health food supplements based on milk for medical use containing probiotics in capsule, tablet and powder form; Dietary supplements containing probiotics for medical purposes in capsule, tablet, and powder form; Dietary supplements
First Use Anywhere: 20180800
First Use in Commerce: Nov 12, 2021

Classification

International Classes
001 005